242 studies found for:    "Pulmonary Emphysema"
Show Display Options
Rank Status Study
1 Unknown  AeriSeal System for Lung Volume Reduction
Conditions: Emphysema;   Chronic Obstructive Airway Disease;   Pulmonary Emphysema;   Lung Diseases
Intervention: Device: AeriSeal System
2 Not yet recruiting Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema
Condition: Pulmonary Emphysema
Interventions: Biological: Mesenchymal stem cells;   Other: Reference therapy: 400 mL of 0.9% NaCl solution
3 Terminated Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR Hydrogel
4 Terminated Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR Hydrogel
5 Recruiting Long Term Follow up Investigation of Endobronchial Valves in Emphysema
Condition: Pulmonary Emphysema
Intervention: Device: Zephyr Endobronchial Valve (EBV)
6 Completed AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema
Conditions: Pulmonary Emphysema;   COPD;   Lung Diseases
Intervention: Device: AeriSeal System
7 Completed Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
Conditions: Pulmonary Emphysema;   Chronic Obstructive Pulmonary Disease
Intervention: Drug: Biologic Lung Volume Reduction (BLVR) - 10 mL Hydrogel
8 Active, not recruiting A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema
Conditions: Pulmonary Emphysema;   Chronic Obstructive Pulmonary Disease(COPD);   Lung Diseases
Intervention: Device: AeriSeal System
9 Completed US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study
Conditions: Pulmonary Emphysema;   Chronic Obstructive Pulmonary Disease
Intervention: Drug: Biologic Lung Volume Reduction (BLVR) - 20 mL Hydrogel
10 Completed US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR Treatment
11 Completed US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
Condition: Pulmonary Emphysema
Intervention: Drug: BLVR System
12 Completed US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR
13 Recruiting Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
Condition: Pulmonary Emphysema
Interventions: Device: Treatment plus Optimal Medical Therapy;   Other: Optimal Medical Therapy
14 Recruiting The Effect and Mechanism of Bronchoscopic Lung Volume Reduction by Endobronchial Valve in Korean Emphysema Patients
Condition: Pulmonary Emphysema
Intervention: Device: Endobronchial valve
15 Recruiting AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation
Conditions: Pulmonary Emphysema;   COPD;   Lung Diseases
Intervention: Device: AeriSeal System
16 Recruiting Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema
Condition: Pulmonary Emphysema
Intervention: Procedure: Bronchoscopy
17 Active, not recruiting Extension Study of Zemaira i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.
Conditions: Emphysema;   Alpha 1-proteinase Inhibitor Deficiency
Intervention: Biological: Alpha 1- proteinase inhibitor [human]
18 Recruiting Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema
Condition: Pulmonary Emphysema
Intervention: Device: Emphysematous Lung Sealant
19 Recruiting Implantation of Endobronchial Valves Versus Intrabronchial Valves in Patients With Severe Heterogeneous Emphysema
Condition: Pulmonary Emphysema
Interventions: Device: EBV implantation;   Device: IBV implantation
20 Completed Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor (API) Deficiency
Conditions: Alpha1-proteinase Inhibitor Deficiency;   Emphysema
Interventions: Biological: Alpha1-proteinase inhibitor;   Other: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years